Combined exercise training reduces IFN-γ and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis

International Immunopharmacology

Volumn 10, Issue 11, 2010, Pages 1415-1419

  Golzari, Zahra ^a   Shabkhiz, Fatemeh ^a   Soudi, Sara ^a,c   Kordi, Mohammad Reza ^a   Hashemi, Seyed Mahmoud ^b,c  

^a UNIVERSITY OF TEHRAN   (Iran)

^b STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Combined exercise training; Cytokines; IFN ; IL 17; IL 4; Multiple sclerosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY EQUILIBRIUM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDURANCE TRAINING; EXERCISE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PLASMA; PRIORITY JOURNAL;

ADULT; CELLS, CULTURED; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; POSTURAL BALANCE; RESISTANCE TRAINING; YOUNG ADULT;

EID: 77958151842     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.08.008     Document Type: Article

References (45)

1. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
2. Compston A., Coles A. Multiple sclerosis. Lancet 2002, 359:1221-1231.
3. Registered A., Login P., Options P., Access S. Environmental factors and multiple sclerosis. Lancet Neurol 2008, 7:268-277.
4. Al-Shammri S., Rawoot P., Azizieh F., AbuQoora A., Hanna M., Saminathan T., et al. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci 2004, 222:21-27.
5. Imitola J., Chitnis T., Khoury S. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther 2005, 106:163-177.
6. Lassmann H., Ransohoff R. The CD4-Th1 model for multiple sclerosis: a crucial re-appraisal. Trends Immunol 2004, 25:132-137.
7. Gutcher I., Urich E., Wolter K., Prinz M., Becher B. Interleukin 18-independent engagement of interleukin 18 receptor - is required for autoimmune inflammation. Nat Immunol 2006, 7:946-953.
8. Weaver C., Harrington L., Mangan P., Gavrieli M., Murphy K. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
9. Stromnes I., Cerretti L., Liggitt D., Harris R., Goverman J. Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells. Nat Med 2008, 14:337-342.
10. Cannella B., Raine C. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 2003, 55:46-57.
11. Zeis T., Graumann U., Reynolds R., Schaeren-Wiemers N. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008, 131:288-303.
12. Goldhammer E., Tanchilevitch A., Maor I., Beniamini Y., Rosenschein U., Sagiv M. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005, 100:93-99.
13. Niessner A., Richter B., Penka M., Steiner S., Strasser B., Ziegler S., et al. Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization?. Atherosclerosis 2006, 186:160-165.
14. Santos R., Tufik S., De Mello M. Exercise, sleep and cytokines: is there a relation?. Sleep Med Rev 2007, 11:231-239.
15. Ribeiro F., Alves A.J., Duarte J.A., Oliveira J. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation?. Int J Cardiol 2010, 141:214-221.
16. Niebauer J. Effects of exercise training on inflammatory markers in patients with heart failure. Heart Fail Rev 2008, 13:39-49.
17. Balen S., Vukeli -Damijani N., Persi V., Ruzi A., Mileti B., Samardiija M., et al. Anti-inflammatory effects of exercise training in the early period after myocardial infarction. Coll Antropol 2008, 32:285.
18. Kohut M., McCann D., Russell D., Konopka D., Cunnick J., Franke W., et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of [beta]-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 2006, 20:201-209.
19. Petersen A., Pedersen B. The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98:1154.
20. Timmons B. Paediatric exercise immunology: health and clinical applications. Exerc Immunol Rev 2005, 11:108-144.
21. Hintzen R., Polman C. Th-cell modulation in multiple sclerosis. Immunol Today 1997, 18:507.
22. Dalgas U., Stenager E., Ingemann-Hansen T. Review: Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance-and combined training. Mult Scler 2008, 14:35.
23. Dennison L., Moss-Morris R., Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev 2009, 29:141-153.
24. Dalgas U., Stenager E., Jakobsen J., Petersen T., Hansen H.J., Knudsen C., et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 2009, 73:1478-1484.
25. Dalgas U., Ingemann-Hansen T., Stenager E. Physical exercise and MS recommendations. Int MS J 2009, 16:5-11.
26. Dalgas U., Stenager E., Jakobsen J., Petersen T., Hansen H.J., Knudsen C., et al. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Mult Scler 2010, 16:480-490.
27. Conraads V., Beckers P., Bosmans J., De Clerck L., Stevens W., Vrints C., et al. Combined endurance/resistance training reduces plasma TNF-{alpha} receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 2002, 23:1854.
28. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-145.
29. Chen Y., Langrish C., Mckenzie B., Joyce-Shaikh B., Stumhofer J., McClanahan T., et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Investig 2006, 116:1317-1326.
30. Huppert J., Closhen D., Croxford A., White R., Kulig P., Pietrowski E., et al. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 2010, 24:1023-1034.
31. Tzartos J., Friese M., Craner M., Palace J., Newcombe J., Esiri M., et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008, 172:146.
32. Durelli L., Conti L., Clerico M., Boselli D., Contessa G., Ripellino P., et al. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann Neurol 2009, 65:499-509.
33. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13:1173-1175.
34. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009, 132:3329-3341.
35. Graber J., Allie S., Mullen K., Jones M., Wang T., Krishnan C., et al. Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol 2008, 196:124-132.
36. Becher B., Giacomini P., Pelletier D., McCrea E., Prat A., Antel J. Interferon- secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-therapy. Ann Neurol 2001, 45:247-250.
37. Makhlouf K., Weiner H., Khoury S. Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS. J Neuroimmunol 2001, 119:145-149.
38. Berghella A., Totaro R., Pellegrini P., Contasta I., Russo T., Carolei A., et al. Immunological study of IFN-1a-treated and untreated multiple sclerosis patients: clarifying IFN mechanisms and establishing specific dendritic cell immunotherapy. Neuroimmunomodulation 2005, 12:29-44.
39. Castellano V., Patel D., White L. Cytokine responses to acute and chronic exercise in multiple sclerosis. J Appl Physiol 2008, 104:1697.
40. Karp C., van Boxel-Dezaire A., Byrnes A., Nagelkerken L. Interferon-[beta] in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10?. Curr Opin Neurol 2001, 14:361.
41. Miller A., Shapiro S., Gershtein R., Kinarty A., Rawashdeh H., Honigman S., et al. Treatment of multiple sclerosis with Copolymer-1 (Copaxone®): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. J Neuroimmunol 1998, 92:113-121.
42. White L., Castellano V., Coy S. Cytokine responses to resistance training in people with multiple sclerosis. J Sports Sci 2006, 24:911-914.
43. Steensberg A., Toft A., Bruunsgaard H., Sandmand M., Halkjar-Kristensen J., Pedersen B. Strenuous exercise decreases the percentage of type 1T cells in the circulation. J Appl Physiol 2001, 91:1708.
44. Surakka J., Romberg A., Ruutiainen J., Aunola S., Virtanen A., Karppi S., et al. Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial. Clin Rehabil 2004, 18:737.
45. Romberg A., Virtanen A., Ruutiainen J., Aunola S., Karppi S., Vaara M., et al. Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study. Neurology 2004, 63:2034.